We assembled and analyzed the largest existing cohort of 790 patients with cohesin-mutant hematologic malignancies and demonstrated that mutations in STAG2 and RAD21 shape the presentation and outcome of AML in unique ways, which can be explained by distinct co-mutational patterns and AML ontogeny. This evidence concerns the gene RAD21 and acute myeloid leukemia.